Muscle atrophy

Muscle mass
#Atrogi #Muscle atrophy #Obesity #Weight loss

GRK2 modulator reduces fat mass while building muscle

Atrogi has revealed positive data from a human trial for its lead candidate ATR-258, a first-in-class small molecule oral GRK2-biased β2-adrenergic modulator.  ATR-258 is designed to target skeletal muscle through a novel GRK2-biased signalling mechanism, with the goal of improving body composition by reducing fat mass while… Read More

#News

Pregnant woman in hospital
#Muscle atrophy #Paediatrics #Prenatal

Successful first prenatal therapy for spinal muscular atrophy

A prenatal therapy for spinal muscular atrophy (SMA) with risdiplam has shown promise in a first-of-its-kind study.  Scientists at St Jude Children’s Research Hospital led the first in utero treatment of SMA with the orally administered drug risdiplam.   More than two years after the child… Read More

#News #Trending News

International Space Station (ISS)
#Age-related diseases (ARDs) #Immunotherapy #Muscle atrophy #University of Central Florida #Vaxxinity

Immunotherapy partnership advances space medicine research

US company Vaxxinity and the University of Central Florida (UCF) have announced plans to work together to advance space medicine research. The research, funded by a grant from the State of Florida, aims to develop Vaxxinity’s active immunotherapies to prevent and mitigate muscle and bone wasting. Read More

#News

Disabled patient having rehabilitation
#Fujita Health University #Japan #Mitochondria #Muscle atrophy #Muscles

Discovery suggests new treatment for muscle atrophy

Researchers in Japan have revealed the key underlying mechanisms in muscle atrophy, paving the way towards potential new treatments. While the disuse of muscles is the most frequent catalyst for muscle atrophy, there are several other possible causes, including chronic diseases, injury and exposure to low-gravity… Read More

#News